GT Biopharma (GTBP) Shares Outstanding (2009 - 2026)
GT Biopharma's Weighted Average Shares Outstanding was 1.55 million in Q2 2026, compared with 93,803 a year earlier and up 28.2% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Shares Outstanding (2009 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding at GT Biopharma came in at 220,530, up 190.6% from FY2024.
- Weighted Average Shares Outstanding has now increased for eight consecutive years, with a five-year compound annual growth rate of 106.7% (FY2020 to FY2025).
- In earlier years, Weighted Average Shares Outstanding was 75,895 in FY2024 (+40.8%), 53,909 in FY2023 (+26.9%), 42,486 in FY2022 (+13.2%) and 37,537 in FY2021 (+542.1%).
- The Q2 2026 figure marks the highest quarterly Weighted Average Shares Outstanding in data going back to Q1 2009.
- The best year-over-year quarter for Weighted Average Shares Outstanding over five years was Q3 2021 (growth of 595.3%); the worst was Q2 2022 (a decline of 6.8%).
- Per Business Quant data, GTBP's Weighted Average Shares Outstanding in the three quarters before Q2 2026 was 1.21 million (Q1 2026), 220,530 (Q4 2025) and 157,629 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.70 Bn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 220,530.00 |
| Sep 30, 2025 | 157,629.00 |
| Jun 30, 2025 | 93,803.00 |
| Mar 31, 2025 | 93,803.00 |
| Dec 31, 2024 | 75,895.00 |
| Sep 30, 2024 | 89,373.00 |
| Jun 30, 2024 | 68,478.00 |
| Mar 31, 2024 | 55,225.00 |
| Dec 31, 2023 | 53,909.00 |
| Sep 30, 2023 | 54,683.00 |
| Jun 30, 2023 | 53,558.00 |
| Mar 31, 2023 | 52,109.00 |
| Dec 31, 2022 | 42,486.00 |
| Sep 30, 2022 | 41,837.00 |
| Jun 30, 2022 | 41,646.00 |
| Mar 31, 2022 | 43,310.00 |
| Dec 31, 2021 | 37,537.00 |
| Sep 30, 2021 | 41,838.00 |
API Access
GT Biopharma Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();